" /> Spastic paraplegia 5a, autosomal recessive - CISMeF





Preferred Label : Spastic paraplegia 5a, autosomal recessive;

Symbol : SPG5A;

CISMeF acronym : SPG5A;

Type : Phenotype, molecular basis known;

Description : The hereditary spastic paraplegias (SPG) are a group of clinically and genetically diverse disorders characterized by progressive, usually severe, lower extremity spasticity; see reviews of Fink et al. (1996) and Fink (1997). Inheritance is most often autosomal dominant (see 182600), but X-linked (see 303350) and autosomal recessive forms also occur. Autosomal recessive forms of SPG include SPG7 (607259), caused by mutation in the paraplegin gene (602783) on chromosome 16q24; SPG11 (604360), caused by mutation in the spatacsin gene (610844) on 15q21; SPG15 (270700), caused by mutation in the ZFYVE26 (612012) on 14q24; SPG18 (611225), caused by mutation in the ERLIN2 gene (611605) on 8p11; SPG20 (275900), caused by mutation in the spartin gene (607111) on 13q12; SPG21 (248900), caused by mutation in the maspardin gene (608181) on 15q21; SPG26 (609195), caused by mutation in the B4GALNT1 gene (601873) on 12q13; SPG28 (609340), caused by mutation in the DDHD1 gene (614603) on 14q22; SPG30 (610357), caused by mutation in the KIF1A gene (601255) on 2q37; SPG35 (612319), caused by mutation in the FA2H gene (611026) on chromosome 16q23; SPG39 (612020), caused by mutation in the;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the cytochrome P450, family 7, subfamily B, polypeptide 1 gene (CYP7B1, 603711.0001);

Laboratory abnormalities : Increased plasma and CSF 27-hydroxycholesterol;

Prefixed ID : #270800;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.